highperformr logo

Mind Medicine (MindMed) Inc.'s Overview

Total employees40
HeadquartersNew York
Founded2019

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company committed to discovering, developing, and deploying psychedelic-inspired medicines and therapies to treat brain health disorders, with a significant focus on conditions like Generalized Anxiety Disorder (GAD) and ADHD. The company leverages a technology-enabled approach, including the application of Artificial Intelligence (AI) and machine learning in areas such as drug discovery, clinical trial optimization, and the development of digital therapeutics. MindMed's pipeline includes innovative treatments derived from psychedelic substances like LSD and MDMA, aiming to provide new hope for patients with unmet medical needs.

Where is Mind Medicine (MindMed) Inc.'s Headquarters?

Mind Medicine (MindMed) Inc. officeMind Medicine (MindMed) Inc. officeMind Medicine (MindMed) Inc. officeMind Medicine (MindMed) Inc. office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the primary hub for corporate strategy, investor relations, U.S. clinical development oversight, and financial operations.

Notable Features:

Situated in the iconic One World Trade Center, a globally recognized landmark known for its modern architecture and state-of-the-art facilities.

Work Culture:

Dynamic, innovative, and mission-driven, characteristic of a pioneering biotech firm. The culture likely emphasizes scientific rigor, collaboration, and the integration of cutting-edge technologies like AI in its research and development processes.

HQ Significance:

The New York City location provides strategic access to global financial markets, leading research institutions, and a diverse talent pool. The prestige of One World Trade Center underscores the company's ambitious vision.

Values Reflected in HQ: The headquarters' location reflects MindMed's values of ambition, innovation, resilience, and a forward-looking commitment to addressing significant global health challenges.

Location:

MindMed operates with a global outlook, conducting clinical trials in North America and Europe. Its international presence supports worldwide research collaborations, engagement with regulatory authorities like the FDA and EMA, and strategic partnerships. The company utilizes global talent and resources, including AI and data science expertise, to advance its pipeline of psychedelic-inspired medicines and digital health technologies for brain disorders.

Street Address:

One World Trade Center, Suite 8500

City:

New York

State/Province:

NY

Country:

USA

Mind Medicine (MindMed) Inc.'s Global Presence

Basel, Switzerland

Address: Viaduktstrasse 8, 4051 Basel, Switzerland

Leverages Switzerland's robust pharmaceutical ecosystem, access to European regulatory bodies, research talent, and facilitates collaboration with international partners.

Buying Intent Signals for Mind Medicine (MindMed) Inc.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Mind Medicine (MindMed) Inc.

As of April 2025, Mind Medicine (MindMed) Inc.' leadership includes:

Robert Barrow - Chief Executive Officer and Director
Schond L. Greenway - Chief Financial Officer
Daniel R. Karlin, M.D., M.A. - Chief Medical Officer
Francois Lilienthal, M.D. - Chief Commercial Officer
Todd Solomon - General Counsel and Corporate Secretary

Investors of Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc. has been backed by several prominent investors over the years, including:

Deep Track Capital, LP
BlackRock Inc.
The Vanguard Group, Inc.
Braidwell LP
RA Capital Management, L.P.
FCM MM Holdings, LP (associated with Savant Addiction Medicine / Scott Freeman)
Notable early individual investors (e.g., Kevin O'Leary)
Public retail investors (NASDAQ: MNMD, Cboe CA: MMED, DE: MMQ)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

Over the past 12 months, Mind Medicine (MindMed) Inc. has made strategic appointments to its executive team, including a new Chief Commercial Officer and a new General Counsel, to support its growth and development pipeline. These changes reflect the company's ongoing efforts to strengthen its leadership as it advances its clinical programs.

Departures

Cynthia Hu, Cynthia Hu departed from her role as General Counsel and Corporate Secretary.

New Appointments:

Francois Lilienthal, M.D., Dr. Francois Lilienthal was appointed as Chief Commercial Officer to lead commercial strategy as MindMed advances its pipeline.
Todd Solomon, Todd Solomon appointed as General Counsel and Corporate Secretary, bringing extensive legal expertise in the biopharmaceutical industry.

Technology (Tech Stack) used by Mind Medicine (MindMed) Inc.

Discover the tools Mind Medicine (MindMed) Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Mind Medicine (MindMed) Inc. Email Formats and Examples

Mind Medicine (MindMed) Inc. commonly uses the email format [first].[last]@mindmed.co for its professional communications. This format is widely adopted within the organization.

[first].[last]@mindmed.co

Format

robert.barrow@mindmed.co

Example

90%

Success rate

News and media

MindMed Press Release / Business WireMay 9, 2024

MindMed Reports First Quarter 2024 Financial Results and Business Highlights

MindMed announced its Q1 2024 financial results, detailing progress in its MM-120 program for GAD, including continued analysis of Phase 2b data and preparations for its End-of-Phase 2 meeting with the FDA. The company emphasized its focus on advancing its pipeline and maintaining a strong financial position....more

MindMed Press Release / Business WireMarch 7, 2024

MindMed Announces Positive Topline 12-Week Durability Data from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

MindMed shared positive 12-week durability data from its Phase 2b trial of MM-120 (lysergide d-tartrate) for Generalized Anxiety Disorder (GAD), showing sustained and clinically meaningful improvements in symptoms, supporting its potential as a long-acting treatment....more

MindMed Press Release / Business WireDecember 14, 2023

MindMed and Lieber Institute for Brain Development Announce Collaboration to Discover and Develop Novel Therapies for Brain Disorders

MindMed announced a research collaboration with the Lieber Institute for Brain Development (LIBD) to analyze LIBD’s extensive genomic and phenotypic data. This partnership aims to identify and validate novel drug targets, potentially utilizing AI and computational biology, to accelerate the development of treatments for neuropsychiatric disorders....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Mind Medicine (MindMed) Inc., are just a search away.